Wuxi Bios Drug Substance And Drug Product Facilities Receives European And Us Fda Approvals
Wuxi Biologics (Wuxi Bio), A Leading Global Contract Research, Development And Manufacturing Organization, Announced That Its Two Drug Substance (Ds) Facilities And A Drug Product (Dp) Facility Located In Wuxi City Received Regulatory Approvals From The European Medicines Agency (Ema) And The Us Food And Drug Administration (Fda).After Passing Online Pre-Approval Inspection (Pai), Wuxi Biologics Received Ema Gmp Certificates For The Commercial Manufacturing Of Two Biologics Developed By Global Clients At Its Mfg4, Mfg5 And Dp2 Facilities. This Is The First Time Mfg5, The Newest Operational Ds Facility With A Total Of 60,000L Capacity, And Dp2, The Second Dp Facility For Vials, Have Been Certified By The Ema, Only 10 Months After They Were Released For Gmp Manufacturing. The Us Fda Also Approved Mfg5 To Manufacture An Innovative Product For A Global Client.Dr. Chris Chen, Ceo Of Wuxi Biologics, Commented,

Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!